Effects of Sarcopenia on the Outcomes and Safety of Chemoradiotherapy Followed by Durvalumab for the Treatment of Patients With Locally Advanced Non-Small Cell Lung Cancer.

Thorac Cancer · 2025 · PMC12355038 · PMID 40814291

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although patients with both a CCI of 3 or higher and decreased SMI showed a trend toward worse OS, the relatively low comorbidity burden may have lessened the negative prognostic effect of sarcopenia.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.